| First Author | Romero-Carramiñana I | Year | 2024 |
| Journal | iScience | Volume | 27 |
| Issue | 6 | Pages | 109863 |
| PubMed ID | 38799559 | Mgi Jnum | J:348993 |
| Mgi Id | MGI:7644908 | Doi | 10.1016/j.isci.2024.109863 |
| Citation | Romero-Carraminana I, et al. (2024) Ablation of Atp5if1 impairs metabolic reprogramming and proliferation of T lymphocytes and compromises mouse survival. iScience 27(6):109863 |
| abstractText | T cells experience metabolic reprogramming to an enhanced glycolysis upon activation. Herein, we have investigated whether ATPase Inhibitory Factor 1 (IF1), the physiological inhibitor of mitochondrial ATP synthase, participates in rewiring T cells to a particular metabolic phenotype. We show that the activation of naive CD4(+) T lymphocytes both in vitro and in vivo is accompanied by a sharp upregulation of IF1, which is expressed only in Th1 effector cells. T lymphocytes of conditional CD4(+)-IF1-knockout mice display impaired glucose uptake and flux through glycolysis, reducing the biogenesis of mitochondria and cellular proliferation after activation. Consequently, mice devoid of IF1 in T lymphocytes cannot mount an effective Th1 response against bacterial infection compromising their survival. Overall, we show that the inhibition of a fraction of ATP synthase by IF1 regulates metabolic reprogramming and functionality of T cells, highlighting the essential role of IF1 in adaptive immune responses. |
